Nyxoah's Genio reduces median apnea — hypopnea index 74.3% in 12 — month study of CCC patients
Nyxoah presented full 12-month ACCCESS pivotal study results for Genio at the ISSS meeting on October 15, 2026. Genio met both primary efficacy endpoints in obstructive sleep apnea patients with complete concentric collapse, reducing breathing disruptions during sleep. No device- or procedure-related serious adverse ev